Candel Therapeutics Inc
NASDAQ:CADL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Candel Therapeutics Inc
NASDAQ:CADL
|
US |
|
L
|
LyondellBasell Industries NV
SWB:DLY
|
UK |
|
Re/Max Holdings Inc
NYSE:RMAX
|
US |
|
P
|
Petroleo Brasileiro SA Petrobras
XHAM:PJXC
|
BR |
|
E
|
E ON SE
BMV:EOANN
|
DE |
|
P
|
Parsons Corp
F:59P
|
US |
|
P
|
Prudential PLC
XBER:PRU
|
UK |
|
Sanlam Ltd
F:LA6A
|
ZA |
|
LG Chem Ltd
KRX:051910
|
KR |
|
Siriuspoint Ltd
NYSE:SPNT
|
BM |
|
A
|
Avantor Inc
F:AVG
|
US |
|
C
|
CNA Financial Corp
SWB:CNH
|
US |
|
Cipher Mining Inc
F:3A9
|
US |
|
S
|
SA Corporate Real Estate Fund Managers (Pty) Ltd
JSE:SAC
|
ZA |
|
America Movil SAB de CV
OTC:AMXOF
|
MX |
|
M
|
Macquarie Group Ltd
OTC:MCQEF
|
AU |
|
Redcare Pharmacy NV
XETRA:RDC
|
NL |
Wall St Price Targets
CADL Price Targets Summary
Candel Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
CADL is 20.69 USD with a low forecast of 9.09 USD and a high forecast of 30.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CADL's stock price target?
Price Target
20.69
USD
According to Wall Street analysts, the average 1-year price target for
CADL is 20.69 USD with a low forecast of 9.09 USD and a high forecast of 30.45 USD.